Fatty Acids, Nonesterified - Metabolism
Research News and Information

Sunday, November 22, 2009

Flip-flop is the rate-limiting step for transport of free fatty acids across lipid vesicle membranes.

Nov 2009 The mechanism of transport of free fatty acids (FFA) across lipid bilayer membranes remains a subject of debate. The debate is whether the rate-limiting step for transport is flip-flop across the membrane or dissociation into the aqueous phase. ... Read more...

Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha.

29 Sep 2009 Alcoholic steatosis is a fundamental metabolic disorder in the progression of alcoholic liver disease. Zinc deficiency is one of the most consistently observed biochemical/nutritional manifestations of alcoholic liver disease. The purpose of this ... Read more...

Regulation of ANKRD9 expression by lipid metabolic perturbations.

28 Sep 2009 Fatty acid oxidation (FAO) defects cause abnormal lipid accumulation in various tissues, which provides an opportunity to uncover novel genes that are involved in lipid metabolism. During a gene expression study in the riboflavin deficient induced ... Read more...

Latest indexed articles for 'Fatty Acids, Nonesterified - Metabolism'

These are the very latest articles for this heading:

• Flip-flop is the rate-limiting step for transport of free fatty acids across lipid vesicle membranes. Nov 2009
• Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha. 29 Sep 2009
• Regulation of ANKRD9 expression by lipid metabolic perturbations. 28 Sep 2009
• Nanoparticles can induce changes in the intracellular metabolism of lipids without compromising cellular viability. 21 Sep 2009
• Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells. 30 Aug 2009
• Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: evidence for PKC activation and oxidative stress-activated signaling pathways. 21 Aug 2009
• Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. 30 Jul 2009
• eNOS, metabolic syndrome and cardiovascular disease. 29 Jul 2009
• How the intestinal peptide transporter PEPT-1 contributes to an obesity phenotype in Caenorhabditits elegans. 19 Jul 2009
• Liver fat and lipid oxidation in humans. 5 Jul 2009
• Accelerated fatty acid oxidation in muscle averts fasting-induced hepatic steatosis in SJL/J mice. 4 Jul 2009
• The second-meal phenomenon is associated with enhanced muscle glycogen storage in humans. 30 Jun 2009
• Effects of arginine supplementation on post-exercise metabolic responses. 28 Jun 2009
• Hostility and minimal model of glucose kinetics in African American women. 24 Jun 2009
• Daily injection of tumor necrosis factor-{alpha} increases hepatic triglycerides and alters transcript abundance of metabolic genes in lactating dairy cattle. 21 Jun 2009
• Free fatty acid kinetics in the late phase of postexercise recovery: importance of resting fatty acid metabolism and exercise-induced energy deficit. 16 Jun 2009
• Preliminary report: inhibition of cellular proteasome activity by free fatty acids. 16 Jun 2009
• Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia. 15 Jun 2009
• Effects of exercise training and diet on lipid kinetics during free fatty acid-induced insulin resistance in older obese humans with impaired glucose tolerance. 14 Jun 2009
• Rimonabant may induce atrial fibrillation. 10 Jun 2009

See a longer list of these articles.

Technical information about 'Fatty Acids, Nonesterified'

Definition: FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form.

Registry Number: 0

Descriptor UI: D005230

Alternative terms: Fatty Acids, Nonesterified; Acids, Nonesterified Fatty; Nonesterified Fatty Acids; Free Fatty Acids; NEFA; Fatty Acids, Free; Acids, Free Fatty;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D10.251.310;

History Note: 68(66)

Technical Notes: DF: note short X ref